Literature DB >> 10460948

Chronic rheumatoid arthritis complicated by myeloperoxidase antineutrophil cytoplasmic antibody-associated nephritis.

N Yorioka1, Y Taniguchi, D Amimoto, H Miyata, M Yamakido, T Taguchi.   

Abstract

We report a myeloperoxidase antineutrophil cytoplasmic antibody-positive rheumatoid arthritis patient who developed necrotizing crescentic glomerulonephritis. Steroid therapy was given combined with an immunosuppressant agent, and double-filtration plasmapheresis was started with the aim of removing antibodies from the blood. This therapeutic regimen was found to be useful.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10460948     DOI: 10.1159/000013494

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  4 in total

1.  AP-VAS 2012 case report: two patients with rheumatoid arthritis suspected of relapsed microscopic polyangiitis after initiation of dialysis.

Authors:  Mai Sugahara; Takahiro Nishi; Shinji Tanaka; Noriaki Kurita; Keiko Sai; Tatsuya Kano; Kyosuke Nishio; Tokuichiro Sugimoto; Naobumi Mise
Journal:  CEN Case Rep       Date:  2013-07-04

Review 2.  Myeloperoxidase-antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis with rheumatoid arthritis: a comparison of patients without rheumatoid arthritis.

Authors:  Noriaki Kurita; Naobumi Mise; Akiko Fujii; Masaya Mori; Keiko Sai; Takahiro Nishi; Takeshi Suzuki; Hitoshi Tagawa; Tokuichiro Sugimoto
Journal:  Clin Exp Nephrol       Date:  2010-03-26       Impact factor: 2.801

3.  Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis.

Authors:  Haiting Wu; Yiyun Lu; Rongrong Hu; Wei Ye; Yubing Wen; Jianfang Cai; Hang Li; Xuemei Li
Journal:  BMC Nephrol       Date:  2022-04-22       Impact factor: 2.585

4.  Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome.

Authors:  Juliana Draibe; Alan D Salama
Journal:  Springerplus       Date:  2015-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.